NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1902831001 M.D.
Verify on CMS → Mark Ellenbogen, M.D.
Pulmonary Disease Physician in Chestnut Hill, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 330 beneficiaries · Pulmonary Disease Physician avg: 1K
What the federal data shows
Mark Ellenbogen, M.D. filed 2,778 Medicare Part D claims in 2024 as a Pulmonary Disease Physician in Chestnut Hill, Massachusetts.
- 3K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥87th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Ellenbogen, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1902831001), first enumerated 07/11/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,778 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Mark Ellenbogen, M.D.'s individual license status. Verify directly with the state medical board.
Source: BORIM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1902831001 · Pulmonary Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1902831001
- ENUM-LEGACY 2006
- TAX-MID 10K Pulmonary Disease
- RX-MID 2,778
- BOOK-THIN 325 in Massachusetts
- PHOTO-ENUM John McConnell, M.D. · 2006
Mark Ellenbogen, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,778 ≥ 87th percentile 87% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Mark Ellenbogen, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Ellenbogen, M.D.?
Quality data not reportedPrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
2,778 85% vs specialty avg
Specialty distribution in Massachusetts
How Pulmonary Disease Physician compares to other specialties among Massachusetts providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1902831001 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/11/2006 |
Hospital and facility affiliations
Facilities where Mark Ellenbogen, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Medical Care OF Boston Management Corporation
Sharon, MA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Mark Ellenbogen, M.D.. To verify Mark Ellenbogen, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,778
Total Claims
$215K
Total Drug Cost
330
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,579.833
- Total Day Supply
- 191,220
- Generic Drug Cost
- $55K
- Opioid Claims
- 77 (2.8% rate)
- Antibiotic Claims
- 88
Patient Demographics
- Average Patient Age
- 77.0 years
- Avg HCC Risk Score
- 1.12
- Gender Split
- 43% female / 57% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mark Ellenbogen, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Atorvastatin Calcium
Atorvastatin Calcium
252 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
130 claims
- Amlodipine Besylate
Amlodipine Besylate
120 claims
- Levothyroxine Sodium
Levothyroxine Sodium
107 claims
- Lisinopril
Lisinopril
104 claims
- Losartan Potassium
Losartan Potassium
102 claims
- Omeprazole 93
Omeprazole
93 claims
- Simvastatin 75
Simvastatin
75 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 252 |
| Rosuvastatin Calcium | 130 |
| Amlodipine Besylate | 120 |
| Levothyroxine Sodium | 107 |
| Lisinopril | 104 |
| Losartan Potassium | 102 |
| Omeprazole | 93 |
| Simvastatin | 75 |
| Metoprolol Succinate | 72 |
| Eliquis Apixaban | 60 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Mark Ellenbogen, M.D. fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Mark Ellenbogen, M.D.'s 2,778 claims are above the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ellenbogen, both outside Massachusetts so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Ellenbogen.
One of 325 Pulmonary Disease Physician providers enrolled in Massachusetts, 5 are shown here.
Dr. Mohammad Abu Hishmeh
M.D
Springfield, MA
Dr. Anjali Ahn
M.D.
Boston, MA
Dr. Robert Aisenberg
MD
Fall River, MA
Dr. Padmastuti Akella
MD
Worcester, MA
Dr. Daniel Alape Moya
MD
Hyannis, MA
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Ellenbogen, M.D.'s specialty? ▼
Mark Ellenbogen, M.D. specializes in Pulmonary Disease Physician and practices in Chestnut Hill, Massachusetts. Credentials: M.D..
How much does Mark Ellenbogen, M.D. prescribe under Medicare Part D? ▼
In 2024, Mark Ellenbogen, M.D. wrote 2,778 Medicare Part D claims totaling $215K in drug costs for 330 beneficiaries.
Where is Mark Ellenbogen, M.D. located? ▼
Mark Ellenbogen, M.D. is located at 850 BOYLSTON ST, Chestnut Hill, MA, 02467. Phone: (617) 732-9900.
What is Mark Ellenbogen, M.D.'s NPI number? ▼
Mark Ellenbogen, M.D.'s National Provider Identifier (NPI) is 1902831001, issued on 07/11/2006.
Does Mark Ellenbogen, M.D. prescribe opioids? ▼
Yes, Mark Ellenbogen, M.D. had 77 opioid claims in 2024 with an opioid prescribing rate of 2.8%.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Mark Ellenbogen, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Mark Ellenbogen, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Rosuvastatin Calcium, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Ellenbogen, M.D. accept Medicare? ▼
Mark Ellenbogen, M.D. appears in CMS Medicare data with 2,778 Part D claims and 330 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Ellenbogen, M.D.'s credentials? ▼
Mark Ellenbogen, M.D.'s NPI is 1902831001 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.